WASHINGTON — The House Oversight Committee on Monday announced an investigation into 12 pharmaceutical companies and their drug-pricing methods, billing it as one of the broadest inquiries in decades into how drug manufacturers set prices.

It is the fulfillment of a pledge from Rep. Elijah Cummings (D-Md.), the committee chairman, who has said he will make high prescription drug costs a top priority in his oversight agenda. One of the committee’s first hearings, set for Jan. 29, will focus on the same topic.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Januvia 100mg. tablet once daily for type II diabetes should have been off patent by now and has an extension until 2022. $442.00 for 30 tabs . Seniors with part D medicare now have a $400. deductible. So? Drug companies get that every year up front $442.00 and then a negotiated price of $94/month through Humana. It is the lobbyists of Pharms that tell congress how to save in medicare Part D but are actually ripping off the consumer and keep their patent extensions worked out with congressional committees and FDA kickbacks. Too our congressman don’t have these same “SAVINGS”. Most people who read this won’t get it. Just saying.

  • It’s about time to get aggressive on high cost of Humalog Insulin that I use to survive dealing with Type 1 diabetes 24 hours a day for past 44 years.

  • Lev, This investigation will be useless to the consumer unless they fully investigate the PBM’s. Does this Oversight Committee not know what occured
    in Ohio,Kentucky,West Virginia,Arkansas,Louisiana and who knows how many other states by the PBM’s ? Maybe someone should tell them !

Your daily dose of news in health and medicine

Privacy Policy